| Home | E-Submission | Sitemap | Editorial Office |  
Journal of Wound Management and Research > Volume 13(2); 2017 > Article
Lee, Son, and Han: Risk Factors of Methicillin-Resistant Staphylococcus Aureus and Pseudomonas Infection in Diabetic Foot Ulcers in Korea



In diabetic foot infection (DFI), risk of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas infection should be considered in selecting empirical antibiotics. The aim of this study is to analyze the risk factors of MRSA and Pseudomonas infection with respect to DFI in Korea to help to choose adequate empirical antibiotics.


This study included 737 patients with diabetic foot ulcers, who were admitted to diabetic wound center of the Korea University Guro Hospital between January 2012 and December 2016. Deep tissue or bone biopsy cultures were taken during surgical debridement in the operating room. Using eight categories of patients’ clinical characteristics (age, gender, smoking history, dialysis, HbA1c, wound duration, TcPO2, previous use of antibiotics), we evaluated the risk factors for MRSA and Pseudomonas aeruginosa infection.


Among the 832 microbial isolates, 114 were MRSA (13.7%) and 78 were Pseudomonas (9.4%), respectively. Wound duration (>4 weeks) was the only statistically significant factor associated with the MRSA infection in univariate and multivariate logistic analysis. For Pseudomonas aeruginosa infection, three factors − gender, smoking history, and HbA1c level (<7.0%) − were found to be statistically significant in univariate analysis. In multivariate analysis, smoking history and previous treatment history emerged as strong predictors for the Pseudomonas aeruginosa infection.


Wound duration can be the risk factor of MRSA infection in diabetic foot ulcers. Regarding Pseudomonas infection, smoking history and previous treatment history can be risk factors.


In the treatment of patients with DFI, major treatment plans are followings; surgical debridement and/or antibiotic use. According to current clinical guideline from Infectious Disease Society of America (IDSA), if there is an infection, surgical debridement should be performed to excise the infected tissue with deep tissue culture obtained. Empirical antibiotics should also be administered until wound cultures define the causative organisms and their antibiotic susceptibility patterns, allowing targeted antibiotics regimens [1,2]. 3–5 days waiting period for results is the critical period for initial infection management, during which most of the clinicians use a broad-spectrum empirical antimicrobial therapy, which covers most of the causative pathogens. In particular, risk factors of MRSA and Pseudomonas infection should be considered for choice of empirical antibiotics [1,2]. Henceforth, it is imperative that primary surgeons know the risk factors of MRSA and Pseudomonas infection in diabetic foot ulcer specific to their own country.
Several studies have attempted to identify risk factors of MRSA infection in western population (North American and European). Previous use of antibiotics, previous hospitalization, and extended duration of the wound in diabetic foot ulcer were noted as risk factors for MRSA infection [3-6]. However, it is difficult to apply the results from the western population to Korean population due to intrinsic limitations such as the difference of prevalence of causative pathogens and characteristics of patients. At the same time, to the best of our knowledge, study on the risk factors of Pseudomonas infection in diabetic foot ulcer with large sample is very limited. To bridge the gaps, this study aims to find risk factors for MRSA and Pseudomonas infection in diabetic foot ulcer using the data of Korean population.



Medical records of 737 patients with diabetic foot ulcers, who were admitted and treated at the diabetic wound center of Korea University Guro Hospital between January 2012 and December 2016, were reviewed. A complete medical history was obtained at the first visit. Based on previous studies, eight risk factors were reviewed for each patient: age, gender, smoking history, dialysis, HbA1c value, wound duration, value of transcutaneous partial oxygen tension (TcpO2) and previous use of antibiotics (Table 1). Furthermore, the aforementioned factors were included in the comparative study for determining infection risk factor of MRSA and Pseudomonas aeruginosa. This study protocol was approved by the Institutional Review Board of Korea University Guro Hospital.

Microbiological Methods

Only intraoperative samples collected from surgical procedures were included in the study. Surgical debridement was performed to remove all non-viable tissue from the wounds. Deep tissue and/or bone specimens were obtained and immediately stored in aseptic tube for culture. The specimens were sent to microbiologic laboratory in the same hospital and incubated at 35˚C for 24–48 hours in Sheep blood agar plate. Furthermore, MacConkey II agar plate was used for aerobes and Chocolate agar plate for anaerobes.

Statistical analysis

Qualitative variables were expressed as percentages, and quantitative variables were expressed as means±standard deviation (SD). To assess the association between the potential risk factors and infection of MRSA and Pseudomonas aeruginosa, univariate analysis was performed (SPSS 12.0 version, SPSS Inc.). Screening for potential risk factors was done using Chi-square test and logistic regression analysis. The P-values <0.20 were considered significant for inclusion in the multivariate analysis. Multivariate linear logistic regression models were formulated and tested to adjust for covariates. Adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated, and P-values <0.05 were considered as statistically significant.


Out of the 737 patients included in this study, 623 patients (84.5%) had isolated causative organisms and 832 microbial isolates were identified. Among 832 isolates, 114 organisms (13.7%) were MRSA as the most common isolated organisms. Pseudomonas aeruginosa was identified by 78 organisms (9.4%).
Analysis of eight potential risk factors for MRSA and Pseudomonas aeruginosa infection is shown in Table 2. As per univariate analysis, wound duration (>4 weeks) was the only statistically significant factor associated with the MRSA infection (P=0.009).
In case of Pseudomonas aeruginosa infection, three factors including gender, smoking history, and HbA1c level (<7.0%) were identified as statistically significant factors. Male patients had a 2.5-fold increased odds for Pseudomonas aeruginosa infection and 1.9-fold for patients with smoking history and 1.8-fold for patients with controlled DM (HbA1c <7.0%) respectively.
Smoking history, HbA1c level, and wound duration were further evaluated in a multiple logistic regression analysis for MRSA infection. In the same way, gender, smoking history, dialysis, HbA1c level, and previous use of antibiotics were evaluated for Pseudomonas aeruginosa infection (Table 3). Only wound duration (>4 weeks) was a significant predictor for the MRSA infection (OR, 2.21; P=0.001). Smoking history and previous treatment emerged as strong predictors for the Pseudomonas aeruginosa infection, whereas gender and HbA1c were no longer found as predictive factors. Patients with a smoking history had a 1.7-fold increased odds for Pseudomonas aeruginosa infection. Similarly, patients previously treated in other hospital had 1.9-fold increased odds for infection.


The prevalence of diabetes worldwide was estimated to be 2.8% in 2000 and is expected to increase to 4.4% in 2030 [2,7]. Epidemiological studies suggest that 2.5% of diabetic patients develop diabetic foot ulcers each year and 15–25% during their lifetime [2,8]. Diabetic foot ulcer can be caused by various risk factors such as peripheral neuropathy, peripheral vascular disease, trauma, and impaired resistant to infection [2,9,10]. DFI is the most frequent and disastrous complication of the diabetic foot [2,11]. It is considered as a serious health and socioeconomic problem than any other diabetes-related complications and is the major cause of non-traumatic lower extremity amputations [2,12].
Staphylococcus aureus is one of the most common pathogens in DFI, as much as 46% of which is MRSA [1]. The prevalence of MRSA in DFI continues to rise, which ranges from 5% to 30% [13,14]. MRSA in DFI is associated with slower healing, more osteomyelitis, and more surgical procedures [15,16]. Maybe for these reasons, it is commonly believed to be an important cause of poor outcomes, increased healthcare cost, and mortality [3,13,17,18]. Pseudomonas aeruginosa is associated with immune-compromised hosts and is relatively uncommon as a cause of DFI in non-tropical, developed countries [19,20]. However, it causes severe tissue damage with its tendency to resist phagocytosis and antibiotics [21]. Furthermore, it can cause sepsis or amputation, so it should always be considered as a possible pathogen [22]. Accordingly, prevention of MRSA and/or Pseudomonas in DFI should be warranted.
This large, single-center study examined the risk factors of MRSA and Pseudomonas infection in diabetic foot ulcer patients. In this study, only deep tissue or bone culture obtained in operating room during surgical debridement were employed, thus ensuring reliable results on true pathogen of DFI.
Previous studies have noted the following risk factors for MRSA DFI: presence of multidrug-resista nt organisms, history of MRSA DFI, previous use of antibiotics, previous hospitalization, and extended duration of the foot wound [3-6,23]. Other studies done in the United States found that males were at a higher risk of developing MRSA infection [14]. Kallen et al found out that patients undergoing chronic dialysis showed the higher incidence of invasive MRSA than the general population. Ding et al showed that HbA1c was a risk factor for the methicillin-resistant Staphylococci infection. In our study, univariate analysis revealed that wound duration (>4 weeks) was the only statistically significant factor associated with the MRSA infection (P=0.009). Interestingly, previous use of antibiotics, which is a well-known factor of MRSA infection, was not found as a statistically significant factor (P=0.699). Multiple logistic regression analysis also revealed wound duration (>4 weeks) as a strong predictor for MRSA infection (P=0.001). Recently, in Korea, not only DFI, but also other MRSA infection have been prevailing due to community-acquired MRSA infection [24,25]. It is probable that health care-associated factors, such as previous use of antibiotics, are less likely the cause of MRSA infection than in the past.
In case of Pseudomonas infection, there exist many studies on its microbiological epidemics and treatment, but there has been no large study that revealed the risk factors for Pseudomonas infection in diabetic foot ulcer. In our study, smoking history and previous use of antibiotics were identified as strong predictors for the Pseudomonas aeruginosa infection. Similarly, in respiratory disease, cigarette smoking has been verified as a risk factor for infection by the opportunistic pathogens like Pseudomonas aeruginosa [26,27]. The underlying mechanism and causes of Pseudomonas aeruginosa infection in diabetic foot ulcers need to be evaluated in future study.
Our previous research has shown that the various phenomena related to diabetic foot ulcers in Korea are different from those in the western. For example, microbiology in DFI was different. The incidence of Gram-negative organisms in Korean population was higher than in western population, among which Pseudomonas was the most common and important organism [2]. Other prior study that our center conducted regarding the risk factors of major amputations in diabetic foot ulcer patients in Korean population also showed the difference. For instance, foot infection was an important risk factor in other countries, but not in Korea. We postulated that the difference was due to the different treatment protocols [28]. Moreover, even in the same geographic area, there was difference by race. A study conducted in the UK examined the difference in the prevalence of diabetic foot ulcers between the Asian and Caucasian population with possible contributing factors. According to the study, prevalence of the ulcers among the Asian population was about three times lower than that of the European population, which is attributed to lower peripheral vascular disease, neuropathy, and foot deformity [29]. It is likely that genetic factors contribute to the racial difference. Future research considering the geographical and racial difference should be conducted, and ultimately it is necessary to establish a specific treatment protocol that is appropriate for Korean population.


In our single-center based, large population study, wound duration (>4 weeks) was identified as the only risk factor for MRSA infection in DFI. In the case of Pseudomonas aeruginosa infection, patient’s history of smoking and previous use of antibiotics were identified as the risk factors by multivariate logistic regression analysis. Our study provides an evidence for the need of empirical antibiotic therapy regimens for DFI specific to local clinical practices. We suggest the need for our own guidelines based on microbiology of Korean population for designing an effective empirical antibiotic treatment.

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Table 1.
Patient demographics (n=737)
Variable Total (n = 737)
Age (year) 64 ± 12.1
 Male 530 (71.9%)
 Female 207 (28.1%)
Smoking history
 Yes 224 (30.3%)
 No 513 (69.7%)
 Yes 167 (22.6%)
 No 570 (77.4%)
HbA1C (%) 7.8 ± 1.6
Wound duration (week) 23.2 ± 6.3
TcPO2 (mmHg) 30.8 ± 23.7
Previous use of antibiotics
 Yes 556 (75.4%)
 No 181 (24.6%)

TcpO2, Transcutaneous partial oxygen tension.

Table 2.
Analysis of risk factors for MRSA and Pseudomonas infection
Risk factor MRSA infection
Pseudomonas infection
Yes No P-value Yes No P-value
Age 0.702 0.717
 ≥ 65 50 (14.7%) 289 (85.3%) 37 (10.9%) 302 (89.1%)
 < 65 64 (15.8%) 342 (84.2%) 41 (10.1%) 365 (89.9%)
Gender 0.710 0.005
 Male 81 (15.0%) 459 (85.0%) 67 (12.4%) 473 (87.6%)
 Female 33 (16.1%) 172 (83.9%) 11 (5.4%) 194 (94.6%)
Smoking history 0.160 0.008
 Yes 31 (12.7%) 214 (87.3%) 36 (14.7%) 209 (85.3%)
 No 83 (16.6%) 417 (83.4%) 42 (8.4%) 458 (91.6%)
Dialysis 0.971 0.071
 Yes 27 (15.3%) 149 (84.7%) 25 (14.2%) 151 (85.8%)
 No 87 (15.5%) 476 (84.5%) 53 (9.4%) 510 (90.6%)
HbA1c 0.189 0.005
 ≥ 7.0% (Uncontrolled DM) 66 (14.0%) 406 (86.0%) 38 (8.1%) 434 (91.9%)
 < 7.0% (Controlled DM) 48 (17.6%) 225 (82.4%) 40 (14.7%) 233 (85.3%)
Wound duration 0.009 0.340
 ≥ 4 weeks 94 (17.4%) 445 (82.6%) 60 (11.1%) 479 (88.9%)
 < 4 weeks 20 (9.7 %) 186 (90.3%) 18 (8.7%) 188 (91.3%)
TcPO2 0.844 0.865
 ≥ 40 mmHg 31 (15.7%) 166 (84.3%) 20 (10.2%) 177 (89.8%)
 < 40 mmHg 83 (15.1%) 465 (84.9%) 58 (10.6%) 490 (89.4%)
Previous use of antibiotics 0.699 0.060
 Yes 80 (15.0%) 454 (85.0%) 63 (11.8%) 471 (88.2%)
 No 34 (16.1%) 177 (83.9%) 15 (7.1%) 196 (92.9%)

TcpO2, Transcutaneous partial oxygen tension.

Table 3.
Multivariate logistic analysis for the MRSA and Pseudomonas infection
Risk factor OR (95% CI) P-value
MRSA infection
 Wound duration (≥ 4 weeks) 2.21 (1.39-3.52) 0.001
 HbA1c (≥ 7.0%, Uncontrolled DM) 0.68 (0.47-0.98) 0.061
Pseudomonas infection
 Smoking history 1.74 (1.03-2.93) 0.037
 Treatment history 1.94 (1.06-3.54) 0.030


1. Lipsky BA, Berendt AR, Cornia PB, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54:e132–73.
crossref pmid pdf
2. Son ST, Han SK, Lee TY, et al. The Microbiology of Diabetic Foot Infections in Korea. J Wound Management Res 2017; 13:8–12.
crossref pdf
3. Richard JL, Sotto A, Jourdan N, et al. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers. Diabetes Metab 2008; 34(4 Pt 1):363–9.
crossref pmid
4. Lavery LA, Armstrong DG, Murdoch DP, et al. Validation of the infectious diseases society of america’s diabetic foot infection classification system. Clin Infect Dis 2007; 44:562–5.
crossref pmid pdf
5. Cavanagh PR, Lipsky BA, Bradbury AW, et al. Treatment for diabetic foot ulcers. Lancet 2005; 366:1725–35.
crossref pmid
6. Ge Y, MacDonald D, Hait H, et al. Microbiological profile of infected diabetic foot ulcers. Diabet Med 2002; 19:1032–4.
crossref pmid
7. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047–53.
crossref pmid
8. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg 1998; 176(2A Suppl):5s–10s.
crossref pmid
9. Khanolkar MP, Bain SC, Stephens JW. The diabetic foot. QJM 2008; 101:685–95.
crossref pmid pdf
10. Noor S, Zubair M, Ahmad J. Diabetic foot ulcer--A review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 2015; 9:192–9.
crossref pmid
11. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, et al. The global burden of diabetic foot disease. Lancet 2005; 366:1719–24.
crossref pmid
12. Van Battum P, Schaper N, Prompers L, et al. Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med 2011; 28:199–205.
crossref pmid
13. Dang CN, Prasad YD, Boulton AJ, et al. Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic. a worsening problem. Diabet Med 2003; 20:159–61.
crossref pmid
14. Eleftheriadou I, Tentolouris N, Argiana V, et al. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs 2010; 70:1785–97.
crossref pmid
15. Tentolouris N, Jude EB, Smirnof I, et al. Methicillin-resistant Staphylococcus aureus. an increasing problem in a diabetic foot clinic. Diabet Med 1999; 16:767–71.
crossref pmid
16. Wang SH, Sun ZL, Guo YJ, et al. Meticillin-resistant Staphylococcus aureus isolated from foot ulcers in diabetic patients in a Chinese care hospital. risk factors for infection and prevalence. J Med Microbiol 2010; 59(Pt 10):1219–24.
crossref pmid
17. Hartemann-Heurtier A, Robert J, Jacqueminet S, et al. Diabetic foot ulcer, multidrug-resistant organisms. risk factors and impact. Diabet Med 2004; 21:710–5.
crossref pmid
18. Aragon-Sanchez J, Lazaro-Martinez JL, Quintana-Marrero Y, et al. Are diabetic foot ulcers complicated by MRSA osteomyelitis associated with worse prognosis? Outcomes of a surgical series. Diabet Med 2009; 26:552–5.
crossref pmid
19. Lipsky BA, Tabak YP, Johannes RS, et al. Skin, soft tissue infections in hospitalised patients with diabetes. culture isolates and risk factors associated with mortality, length of stay and cost. Diabetologia 2010; 53:914–23.
crossref pmid
20. Citron DM, Goldstein EJ, Merriam CV, et al. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007; 45:2819–28.
crossref pmid pmc
21. Baltimore RS. Nelson Textbook of Pediatrics. Philadelphia, W.B. Saunders Co. 2000, pp 862–4.

22. Mike E. The use of antibiotics in the diabetic foot. Am J Surg 2004; 187:S25–8.
23. Lavery LA, Fontaine JL, Bhavan K, et al. Risk factors for methicillin-resistant Staphylococcus aureus in diabetic foot infections. Diabet Foot Ankle 2014; 5.
24. Park SH, Park C, Yoo JH, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infect Control Hosp Epidemiol 2009; 30:146–55.
crossref pmid
25. Joo EJ, Chung DR, Ha YE, et al. Community-associated Panton-Valentine leukocidin-negative meticillin-resistant Staphylococcus aureus clone (ST72-MRSA-IV) causing healthcareassociated pneumonia and surgical site infection in Korea. J Hosp Infect 2012; 81:149–55.
crossref pmid
26. Gally F, Chu HW, Bowler RP. Cigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infection. PLoS One 2013; 8:e51784.
crossref pmid pmc
27. Vij N, Chandramani P, Westphal CV, et al. Cigarette smoke induced autophagy-impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis. Am J Physiol Cell Physiol 2016; ajpcell.00110.2016.
28. Namgoong S, Jung SY, Han SK, et al. Risk factors for major amputation in hospitalised diabetic foot patients. Int Wound J 2016; 13 Suppl 1:13–9.
crossref pmid
29. Abbott CA, Garrow AP, Carrington AL, et al. Foot ulcer risk is lower in South-Asian and African-Caribbean compared with European diabetic patients in the UK. Diabetes Care 2005; 28:1869–75.
crossref pmid
Editorial Office
Department of Plastic & Reconstructive Surgery, Dankook University Hospital
201 Manghyang-ro, Dongnam-gu, Cheonan 31116, Korea
TEL: +82-41-550-6285   FAX: +82-41-556-0524   E-mail: office@jwmr.org
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Wound Management Society. All rights reserved.                 Developed in M2community
Close layer
prev next